Marjolein van der Poel

Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study

Brink, M., Kahle, X. U., Vermaat, J. S. P., Zijlstra, J. M., Chamuleau, M., Kersten, M. J., Durmaz, M., Plattel, W. J., Lugtenburg, P. J., Stevens, W., Mous, R., de Vries, E. G. E., van der Poel, M. W. M., Panday, P. V. N., Huls, G., van Meerten, T. & Nijland, M., 10 Aug 2021, In: Blood advances. 5, 15, p. 2958-2964 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., van der Klift, M. & 15 others, van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B., Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) & Swiss Group for Clinical Cancer Research (SAKK), Oct 2020, In: Leukemia. 34, 10, p. 2820-2820 1 p., 2820.

Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS

Huls, G., Chitu, D. A., Pabst, T., Klein, S. K., Stussi, G., Griskevicius, L., Valk, P. J. M., Cloos, J., van de Loosdrecht, A. A., Breems, D., van Lammeren-Venema, D., van Zeventer, I., Boersma, R., Jongen-Lavrencic, M., Fehr, M., Hoogendoorn, M., Manz, M. G., Sohne, M., Kooy, R. V. M., Deeren, D. & 10 others, van der Poel, M. W. M., Legdeur, M. C., Tick, L., Chalandon, Y., Ammatuna, E., Blum, S., Lowenberg, B., Ossenkoppele, G. J., Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) & Swiss Group for Clinical Cancer Research (SAKK), 22 Sep 2020, In: Blood advances. 4, 18, p. 4267-4277 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

Lazaryan, A., Dolan, M., Zhang, M-J., Wang, H-L., Kharfan-Dabaja, M. A., Marks, D. I., Bejanyan, N., Copelan, E., Majhail, N. S., Waller, E. K., Chao, N., Prestidge, T., Nishihori, T., Kebriaei, P., Inamoto, Y., Hamilton, B., Hashmi, S. K., Kamble, R. T., Bacher, U., Hildebrandt, G. C. & 31 others, Stiff, P. J., McGuirk, J., Aldoss, I., Beitinjaneh, A. M., Muffly, L., Vij, R., Olsson, R. F., Byrne, M., Schultz, K. R., Aljurf, M., Seftel, M., Savoie, M. L., Savani, B. N., Verdonck, L. F., Cairo, M. S., Hossain, N., Bhatt, V. R., Frangoul, H. A., Abdel-Azim, H., Al Malki, M., Munker, R., Rizzieri, D., Khera, N., Nakamura, R., Ringdén, O., van der Poel, M., Murthy, H. S., Liu, H., Mori, S., De Oliveira, S. & Acute Leukemia Committee of the CIBMTR, 1 May 2020, In: Haematologica-the Hematology Journal. 105, 5, p. 1329-1338 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma

Ahmed, S., Ghosh, N., Ahn, K. W., Khanal, M., Litovich, C., Mussetti, A., Chhabra, S., Cairo, M., Mei, M., William, B., Nathan, S., Bejanyan, N., Olsson, R. F., Dahi, P. B., van der Poel, M., Steinberg, A., Kanakry, J., Cerny, J., Farooq, U., Seo, S. & 4 others, Kharfan-Dabaja, M. A., Sureda, A., Fenske, T. S. & Hamadani, M., 1 Aug 2020, In: British Journal of Haematology. 190, 4, p. 573-582 10 p.

Research output: Contribution to journal › Article › Academic › peer-review